Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Blood pressure control in kidney transplantation: therapeutic implications

Journal of Human Hypertension volume 18, pages 871–877 (2004)Cite this article

Abstract

Post-transplant hypertension remains a significant risk factor for graft loss, but whether or not specific blood pressure (BP) medications affect graft outcome is still unknown. We assessed the interaction between BP control and antihypertensive drugs on graft outcome. We retrospectively examined clinic BP data for 1662 renal transplant (RTx) patients, transplanted between 1994 and 2000 at our centre. The analysis examined all patients who received central α-agonists and peripheral α-antagonists, beta-blockers, calcium channel blockers (CCBs), angiotensin-converting enzyme (ACE) inhibition (ACEI), angiotensin receptor blockers (ARBs). BP recordings during treatment were categorized for each agent. Thus, a particular BP could be categorized for multiple medications. A total of 1462 patients (pts) (88%) were Caucasian and 800 pts (46%) received cadaveric RTx. There were 10.6±6.8 BP measurements for each patient post-RTx. CCBs, alone among the classes of antihypertensive drugs evaluated, reduced the risk for graft loss (RR: 0.736; P=0.035) in the overall analysis. Interestingly, stratifying levels of BP control unmasked a beneficial effect on graft survival of ACEI/ARB therapy in individuals with higher levels of systolic (>152 mmHg) and diastolic blood pressure (>98 mmHg) treated with ACEI/ARBs compared to individuals treated with CCBs (P<0.01 for each). Thus, stabilizing BP is important post-RTx. CCBs are associated with improved rates of graft survival. Their role in a compromised RTx, however, deserves further study. ACEI/ARBs have clear benefits, improving graft survival in individuals with elevated systolic blood pressure and proteinuria. CCBs are not as efficacious in this setting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hariharan S et al. Improved graft survival after renal transplantation in the United States 1988 to 1996. N Engl J Med 2000; 342: 605–612.

    Article  CAS  Google Scholar 

  2. First MR, Neylan JF, Rocher LL, Tejani A . Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4: S30–S36.

    CAS  PubMed  Google Scholar 

  3. van der Schaaf MR et al. Hypertension after renal transplantationCalcium channel or converting enzyme blockade? Hypertension 1995; 25: 77–81.

    Article  CAS  Google Scholar 

  4. Opelz G, Wujciak T, Ritz E . Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53: 217–222.

    Article  CAS  Google Scholar 

  5. Mange KC, Cizman B, Joffe M, Feldman HI . Arterial hypertension renal allograft survival. JAMA 2000; 283: 633–638.

    Article  CAS  Google Scholar 

  6. Cosio FG et al. Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. Kidney Int 2001; 59: 1158–1164.

    Article  CAS  Google Scholar 

  7. Raman GV et al. Modifying effects of amlodipine on cyclosporin. A-induced changes in renal function in patients with psoriasis. J Hypertens Suppl 1998; 16: S39–S41.

    CAS  PubMed  Google Scholar 

  8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD . The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456–1462.

    Article  CAS  Google Scholar 

  9. Fleming JT, Parekh N, Steinhausen M . Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol 1987; 253: F1157–F1163.

    CAS  PubMed  Google Scholar 

  10. English J, Evan A, Houghton DC, Bennett WM . Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987; 44: 135–141.

    Article  CAS  Google Scholar 

  11. Ruggenenti P et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43: 706–711.

    Article  CAS  Google Scholar 

  12. Becker BN, Jacobson LJ, Hullett DA . An antigen-independent important hormone:intrarenal angiotensin II (AII) as a key to understanding chronic allograft nephropathy. Graft 2002; 5: 199–204.

    Article  CAS  Google Scholar 

  13. Stigant CE, Cohen J, Vivera M, Zaltzman JS . ACE inhibitors angiotensin II antagonists in renal transplantation: an analysis of safety efficacy. Am J Kidney Dis 2000; 35: 58–63.

    Article  CAS  Google Scholar 

  14. Midtvedt K, Hartmann A . Hypertension after kidney transplantation: are treatment guidelines emerging? Nephrol Dial Transplant 2002; 17: 1166–1169.

    Article  Google Scholar 

  15. Dudley CR . Treatment of posttransplant hypertension: ACE is trumped? Transplantation 2001; 72: 1728–1729.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a Merck Medical School Grant (BNB), a grant from Novartis (BNB), and by NIH Grants 1RO1-AI49285-03 (BNB) and 1K24 DK616962-02 (BNB).

Author information

Authors and Affiliations

  1. Department of Medicine, University of Wisconsin, Madison, WI, USA

    N C Premasathian, R Muehrer, P C Brazy, J D Pirsch & B N Becker

Authors
  1. N C Premasathian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Muehrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P C Brazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J D Pirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B N Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B N Becker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Premasathian, N., Muehrer, R., Brazy, P. et al. Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens 18, 871–877 (2004). https://doi.org/10.1038/sj.jhh.1001767

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001767

Keywords

This article is cited by

Search

Advanced search

Quick links